Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Resistance to skin carcinogenesis in PARP-1 knockout mice due to a defective inflammatory response

D. Martin-Oliva

Med Sci Monit 2003; 9(1): 39-0 :: ID: 15102

Abstract

It is well known that inflammation is a key component in the initiation and progression of epithelial cancer [1]. In a recent studies [2] we have established that the absence of PARP-1 is able to slow down tumour formation and to increase the lifespan of p53 deficient mice. We and others have shown that PARP-1 is a transcriptional co-activator of NF-kB and PARP-1 knockout as a result of a diminished release of pro-inflammatory mediators, including NO [3,4]. In the present report we have studied the susceptibility to skin carcinogenesis in mice deficient for poly(ADP-ribose) polymerase-1. In PARP-1–/– mice development of skin tumours induced by initiation with DMBA and promotion with TPA is strongly delayed, and the final number of tumour-bearing mice and total tumour number were significantly decreased in genetically deficient mice for PARP-1. The early stages of TPA promotion are characterized by keratinocyte hyperproliferation and inflammation. Nonetheless, epidermis of PARP-1–/– mice did not show increased proliferation rates. Derregulated NF-kB has been proven to be a hallmark for tumorigenesis together with the concomitant release of early inflammatory mediators, such as TNF-a. In the absence of PARP-1 NF-kB activation and induction of TNF-a did not take place during the initiation of tumour development in cell extracts from the epidermis of the carcinogen-treated area. In view of the important roles of NF-kB in tumour promotion/progression, these results suggest that inhibition of tumour development by the abolition of PARP-1 may be mediated by impairing signal transduction pathways leading to activation of NF-kB. References: 1.Correa P: Cancer Res, 1992; 52; 6735-6740 2.Conde C, Mark M, Oliver FJ et al: EMBO Journal, 2001; 20: 3535-3543 3.Oliver FJ, Ménissier de Murcia J, Nacci C et al: EMBO Journal, 1999; 18: 4446-4454 4.Hassa PO, Covic M, Hasan S et al: J Biol Chem, 2001 Dec 7; 276(49): 45588-97

Keywords: PARP-1 knockout mice, skin carcinogenesis, NF-kB, TNF-a

Add Comment 0 Comments

Editorial

01 April 2024 : Editorial  

Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance

Dinah V. Parums

DOI: 10.12659/MSM.944600

Med Sci Monit 2024; 30:e944600

0:00

In Press

05 Mar 2024 : Clinical Research  

Muscular Function Recovery from General Anesthesia in 132 Patients Undergoing Surgery with Acceleromyograph...

Med Sci Monit In Press; DOI: 10.12659/MSM.942780  

05 Mar 2024 : Clinical Research  

Effects of Thermal Insulation on Recovery and Comfort of Patients Undergoing Holmium Laser Lithotripsy

Med Sci Monit In Press; DOI: 10.12659/MSM.942836  

05 Mar 2024 : Clinical Research  

Role of Critical Shoulder Angle in Degenerative Type Rotator Cuff Tears: A Turkish Cohort Study

Med Sci Monit In Press; DOI: 10.12659/MSM.943703  

06 Mar 2024 : Clinical Research  

Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943797  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750